Janus Kinase Inhibitors: Modulating Immune Responses
Janus kinase inhibitors regulate immune signaling pathways involved in inflammation and autoimmune disorders. They help control abnormal immune activity.
These therapies are increasingly used in chronic inflammatory conditions due to their oral administration and targeted action.
FAQs
Q1: What conditions do they address?
A1: Autoimmune and inflammatory disorders.
Q2: How do they work?
A2: By blocking specific immune signaling pathways.
16 Views